FDA Approved: LOXAPINE — Supplemental Application (Elite Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LOXAPINE (loxapine) by Elite Laboratories, Inc. under ANDA076868, approving changes to the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• LOXAPINE (loxapine)

Snippet

SUPPL AP for LOXAPINE (LOXAPINE)